Amyloid Beta Hypothesis: Attention to β- and γ-Secretase Modulators | IntechOpen
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance - McCaw - 2021 - The Oncologist - Wiley Online Library
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
The γ-secretase inhibitors used in clinical trial for the treatment of... | Download Scientific Diagram
PDF) Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD | Mark Meadowcroft and charles e albright -
Gamma-secretase Inhibition | Gamma-secretase Inhibitor Review
g-Secretase inhibitors recently or currently in clinical trials for the... | Download Scientific Diagram
Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical Trials Arena
More Evidence that γ-Secretase Modulators Spare Essential Substrates | ALZFORUM
A summary of the clinical trials based on passive γ-secretase... | Download Table
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine
γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression
Chemical structure of γ-secretase inhibitors | Download Table
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead - ScienceDirect
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine
γ-secretase inhibitors: Notch so bad | Nature Medicine
Turning the tide on Alzheimer's disease: modulation of γ-secretase | Cell & Bioscience | Full Text
RO4929097 | ≥99%(HPLC) | Selleck | Gamma-secretase inhibitor
Turning the tide on Alzheimer's disease: modulation of γ-secretase | Cell & Bioscience | Full Text
Semagacestat Is a Pseudo-Inhibitor of γ-Secretase - ScienceDirect
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical Trials Arena
γ-Secretase inhibitors repress thymocyte development | PNAS
Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease | Molecular Neuroscience
